发明名称 |
NOVEL COMPOSITION FOR EXTRACORPOREAL REDUCTION OF BETA AMYLOIDS AND PROCESS FOR PRODUCING THEREOF |
摘要 |
<p>The present invention provides a safe reliable and economical process for preparing an improved dialysis fluid formulation effective for extracorporeal treatment through a blood filtration process of a Beta Amyloid associated pathological condition in a subject said process comprises preparing a composition comprising KLVFF peptide or a variant thereof as the capturing and binding agent and a carrier therefor and mixing said composition with a dialysate solution. The process utilizes a compact inexpensive and simple standard dialysis machine that extracorporeally removes Beta Amyloids without allowing escape of the Beta Amyloids back into a subject s body without having to intricately evaluate the performance and characteristics of a dialysis membrane and without putting the health condition of the subject at risk.</p> |
申请公布号 |
IN2137MUN2014(A) |
申请公布日期 |
2015.08.21 |
申请号 |
IN2014MU02137 |
申请日期 |
2014.10.27 |
申请人 |
AMYLEX PHARMACEUTICALS INC |
发明人 |
SANTOS ROGELIO B. JR.;STEIN STANLEY;KASINATHAN CHINNASWAMY |
分类号 |
C07K1/22;A61M1/14;A61M1/34 |
主分类号 |
C07K1/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|